Triple-negative breast cancer in Peru: 2000 patients and 15 years of experience

被引:14
作者
De-la-Cruz-Ku, Gabriel [1 ]
Luyo, Marianne [2 ]
Morante, Zaida [3 ]
Enriquez, Daniel [3 ]
Moller, Mecker G. [4 ]
Chambergo-Michilot, Diego [1 ,5 ]
Flores, Lucero [1 ]
Luque, Renato [1 ,6 ]
Saavedra, Antonella [1 ,6 ]
Eyzaguirre-Sandoval, Miguel E. [1 ,6 ]
Lujan-Peche, Maria G. [1 ,6 ]
Noel, Naysha [1 ]
Calderon, Hafid [1 ,6 ]
Razuri, Cesar [7 ]
Fuentes, Hugo A. [3 ]
Manuel Cotrina, Jose [3 ]
Neciosup, Silvia P. [3 ]
Araujo, Jhajaira [8 ]
Lema, Alexandra [9 ]
Pinto, Joseph [8 ]
Gomez, Henry L. [3 ]
Valcarcel, Bryan [10 ]
机构
[1] Univ Cient Sur UCSUR, Sch Med, Lima, Peru
[2] Univ Peruana Cayetano Heredia, Lima, Peru
[3] Inst Nacl Enfermedades Neoplas, Lima, Peru
[4] Univ Miami, Miller Sch Med, Div Surg Oncol, Jackson Mem Hosp,Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA
[5] Tau RELAPED Grp, Trujillo, Peru
[6] Soc Cient Estudiantes Med Humana SCIEM UCSUR, Lima, Peru
[7] Hosp Nacl Mayo, Lima, Peru
[8] Oncosalud AUNA, Unidad Invest Basica & Translac, Lima, Peru
[9] Univ Cuenca, Hlth Sci Fac, Cuenca, Ecuador
[10] George Washington Univ, Milken Inst Sch Publ Hlth, Washington, DC 20052 USA
来源
PLOS ONE | 2020年 / 15卷 / 08期
关键词
FAMILY-HISTORY; SURVIVAL; WOMEN; PROGNOSIS; SUBTYPES; IMPACT; ASSOCIATION; RECURRENCE; MASTECTOMY; OUTCOMES;
D O I
10.1371/journal.pone.0237811
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Epidemiological studies commonly identify the clinical characteristics and survival outcomes of patients with breast cancer at five years. Our study aims to describe the sociodemographic, clinicopathological characteristics and determine the long-term event-free survival (EFS) and overall survival (OS) of a Peruvian population with triple-negative breast cancer. Methods We reviewed the medical records of new cases treated at a single institution in the period 2000-2014. The survival analysis included patients with stages I-IV. Survival estimates at 10 years were calculated with the Kaplan-Meier method and compared with the Log-rank test. We further used multivariate Cox regression analysis to calculate prognostic factors of recurrence and mortality. Results Among the 2007 patients included, the median age at diagnosis was 49 years (19-95 years). Most patients presented histologic grade III (68.7%), tumor stage II (34.2%), and III (51.0%) at diagnosis. Local and distant relapse was present in 31.9 and 51.4% of the patients, respectively. The most frequent sites of metastasis were the lungs (14.5%), followed by bone (9.7%), brain (9.6%), and liver (7.9%). The median follow-up was 153 months. At 3, 5, and 10 years, the EFS of the population was 55%, 49%, and 41%, respectively, while the OS was 64%, 56%, and 47%, respectively. Moreover, an N3 lymph node status was the most important prognostic factor for both disease relapse (HR: 2.54, 95% CI: 2.05-3.15) and mortality (HR: 2.51, 95% CI: 2.01-3.14) at ten years. An older age and higher T staging were associated with a worse OS, while patients who received radiotherapy and adjuvant chemotherapy had better survival rates. Conclusion The sociodemographic features of Peruvian patients with TNBC are similar to those of other populations. However, our population was diagnosed at more advanced clinical stages, and thus, EFS and OS were lower than international reports while prognostic factors were similar to previous studies.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] Expression and prognostic value of estrogen receptor β in patients with triple-negative and triple-positive breast cancer
    Guo, Liying
    Zhu, Qianwen
    Aisimutuola, Mulati
    Yilamu, Dilimina
    Liu, Sha
    Jakulin, Adina
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 9 (06) : 2147 - 2150
  • [32] Survival Study of Triple-Negative and Non-Triple-Negative Breast Cancer in a Brazilian Cohort
    Goncalves, Homero, Jr.
    Guerra, Maximiliano Ribeiro
    Duarte Cintra, Jane Rocha
    Fayer, Vivian Assis
    Brum, Igor Vilela
    Bustamante Teixeira, Maria Teresa
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2018, 12
  • [33] Patterns of care and outcomes among triple-negative early breast cancer patients in South Western Sydney
    Naher, Sayeda
    Tognela, Annette
    Moylan, Eugene
    Adams, Diana H.
    Kiely, Belinda E.
    INTERNAL MEDICINE JOURNAL, 2018, 48 (05) : 567 - +
  • [34] Local Treatment of Triple-Negative Breast Cancer
    Machiels, Melanie
    Kaidar-Person, Orit
    Rubio, Isabel T.
    Poortmans, Philip
    CANCER JOURNAL, 2021, 27 (01) : 32 - 40
  • [35] Brain Metastasis in Triple-Negative Breast Cancer
    Bustamante, Eduarda
    Casas, Fresia
    Luque, Renato
    Piedra, Luis
    Barros-Sevillano, Shamir
    Chambergo-Michilot, Diego
    Torres-Roman, J. Smith
    Narvaez-Rojas, Alexis
    Morante, Zaida
    Enriquez-Vera, Daniel
    Desai, Anshumi
    Razuri, Cesar
    de la Cruz-ku, Gabriel
    Araujo, Jhajaira
    BREAST JOURNAL, 2024, 2024
  • [36] Locoregional treatments for triple-negative breast cancer
    Eiermann, W.
    Vallis, K. A.
    ANNALS OF ONCOLOGY, 2012, 23 : 30 - 34
  • [37] Effect of neoadjuvant chemotherapy in patients with triple-negative breast cancer: A meta-analysis
    Tian, Muyou
    Zhong, Yahua
    Zhou, Fuxiang
    Xie, Conghua
    Zhou, Yunfeng
    Liao, Zhengkai
    ONCOLOGY LETTERS, 2015, 9 (06) : 2825 - 2832
  • [38] Prognostic Factors for Triple-Negative Breast Cancer Patients Receiving Preoperative Systemic Chemotherapy
    Asaga, Sota
    Kinoshita, Takayuki
    Hojo, Takashi
    Suzuki, Junko
    Jimbo, Kenjiro
    Tsuda, Hitoshi
    CLINICAL BREAST CANCER, 2013, 13 (01) : 40 - 46
  • [39] Effectiveness of adjuvant chemotherapy for elderly patients with triple-negative breast cancer
    Guo, Qiusheng
    Lan, Tian
    Lu, Yunyan
    Hu, Zujian
    Xu, Haibin
    Wang, Xiaojia
    Shao, Xiying
    Fu, Xueyan
    BIOMOLECULES AND BIOMEDICINE, 2023, 23 (03): : 502 - 509
  • [40] Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer
    Jung, So-Youn
    Kim, Hyun Yul
    Nam, Byung-Ho
    Min, Sun Young
    Lee, Seung Ju
    Park, Chansung
    Kwon, Youngmee
    Kim, Eun-A
    Ko, Kyoung Lan
    Shin, Kyung Hwan
    Lee, Keun Seok
    Park, In Hae
    Lee, Seeyoun
    Kim, Seok Won
    Kang, Han-Sung
    Ro, Jungsil
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 120 (03) : 627 - 637